pembrolizumab,carboplatin
merck
['impact,(-impacte),(-impacti),(-impactf)', 'nsclc', 'keynote-407', 'sclc']
 keynote-407 5 year update combination of pem/carbo/taxol in 1st line sqnsclc 5 year os 23.3% in pdl1 &gt;50% good demonstration that combination chemo-immunotherapy has durable long term impact. #esmo2022 
Thoracic Medical Oncologist @BartsHospital, PhD in genomic medicine @Imperialcollege, Representative @ACPUK & @BTOGorg, @FMLM_UK clinical Fellow ‘18 #SE15